Finance

Lists
ETON:NASDAQ
Eton Pharmaceuticals Inc
55,21 USD
+0,84%
(+0,46) 1D
55,62 USD
+0,74% (+0,41)
After hours
Closed: 9-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ETON...
Open
54,86 USD
High
56,35 USD
Low
54,20 USD
Mkt. cap
1,58 млд
Avg. vol.
582,62 миң
Volume
371,14 миң
P/E ratio
143,12
52-wk high
66,37 USD
52-wk low
14,27 USD
EPS
0,39 USD
Beta
0,90
Shares outstanding
28,58 млн
No. of employees
44
Open
54,86 USD
High
56,35 USD
Low
54,20 USD
Mkt. cap
1,58 млд
Avg. vol.
582,62 миң
Volume
371,14 миң
P/E ratio
143,12
52-wk high
66,37 USD
52-wk low
14,27 USD
EPS
0,39 USD
Beta
0,90
Shares outstanding
28,58 млн
No. of employees
44
News stories
From web sources and news partners
About Eton Pharmaceuticals Inc
CEO-
Employees44
Founded2017
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 3 analysts giving stock ratings to ETON in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ETON in the last 3 months.
Highest
Current 55,21 USD
76,00 USD (+37,66%)
Average
68,67 USD (+24,38%)
Lowest
60,00 USD (+8,68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
70,00 USD
+26,8%
10/01/2026
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
76,00 USD
+37,7%
08/14/2026
Gary Nachman
Canaccord Genuity
Buy
Reiterated
60,00 USD
+8,7%
07/30/2026
Madison Elsaadi
B. Riley Securities
Buy
Reiterated
40,00 USD
-27,5%
06/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
22,46 млн
21,28 млн
24,27 млн
37,59 млн
Cost of goods sold
13,28 млн
6,76 млн
9,18 млн
11,53 млн
Cost of revenue
13,28 млн
6,76 млн
9,18 млн
11,53 млн
Research and development expenses
1,11 млн
1,78 млн
1,88 млн
993,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,11 млн
8,28 млн
10,45 млн
11,63 млн
Operating expense
9,22 млн
10,06 млн
12,32 млн
12,62 млн
Total operating expenses
22,50 млн
16,82 млн
21,50 млн
24,14 млн
Operating income
-39,00 миң
4,47 млн
2,76 млн
13,44 млн
Other non operating income
-
-
-
-
EBT including unusual items
-1,96 млн
1,41 млн
1,57 млн
11,72 млн
EBT excluding unusual items
-631,00 миң
3,42 млн
1,92 млн
12,37 млн
Income tax expense
-28,00 миң
-69,00 миң
20,00 миң
140,00 миң
Effective tax rate
1,43%
-4,88%
1,27%
1,19%
Other operating expenses
-
-
-
-
Net income
-1,93 млн
1,48 млн
1,55 млн
11,58 млн
Net profit margin
-8,58%
6,97%
6,40%
30,80%
Earnings per share
0,04
0,19
0,14
0,43
Interest and investment income
620,00 миң
158,00 миң
296,00 миң
-
Interest expense
-1,21 млн
-1,21 млн
-1,14 млн
-1,08 млн
Net interest expenses
-592,00 миң
-1,05 млн
-840,00 миң
-1,08 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
970,00 миң
5,48 млн
3,90 млн
14,83 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору